Human herpesvirus 6 myelitis after chimeric antigen receptor T-cell therapy.

Human herpesvirus 6 myelitis after chimeric antigen receptor T-cell therapy. Int J Infect Dis. 2021 Nov; 112:327-329.

View in: PubMed